Skip to main content
. 2023 Aug 29;15(8):e44314. doi: 10.7759/cureus.44314

Table 3. Safety analysis.

SAE: Serious adverse events, AE: Adverse events, MACE: Major adverse cardiovascular events

All values are presented as risk ratio (95% confidence interval)

Groups SAE MACE-4 AE
10 mg vs 5 mg 0.93 (0.73-1.20) 0.99 (0.57-1.74) 1.20 (1.10-1.43)
15 mg vs 5 mg 0.84 (0.65-1.09) 0.67 (0.36-1.25) 1.26 (1.05-1.50)
15 mg vs 10 mg 0.90 (0.69-1.17) 0.68 (0.36-1.28) 1.04 (0.87-1.25)